5/3/2009
|
Provid and Fast Forward, LLC Announce Partnership for
Development of PV-267 for Multiple Sclerosis
|
5/3/2009
|
Lawrence Steinman, MD Joins Provid's Scientific Advisory Board
|
9/3/2008
|
Acesys Pharmatech and Provid Pharmaceuticals Inc. announce a
strategic alliance
|
6/10/2008
|
The Leukemia & Lymphoma Society and Provid Pharmaceuticals
Announce Collaboration on Treatment for Acute Myelogenous Leukemia
|
12/5/2007
|
Expert drug discovery
service companies, iNovacia and Provid, establish strategic alliance
|
9/10/2007
|
Provid CEO leads panel at
Pharma ChemOutsourcing conference
|
12/19/2006
|
Edison Innovation
Fund Makes Investment in North Brunswick-Based Provid Pharmaceuticals
|
10/17/2005
|
Provid Pharmaceuticals to
Support Drug Discovery for Palatin Technologies
|
9/29/2005
|
Provid
Announces New National Cancer Institute Contract
|
5/10/2005
|
Provid Pharmaceuticals announces move to
expanded laboratories in North Brunswick,NJ
|
5/10/2005
|
Provid Pharmaceuticals Announces Celiac
Disease Program and Grant
|
4/20/2005
|
Commission names first New Jersey Technology Fellows
|
3/1/2005
|
Provid Pharmaceuticals receives
SBIR grant to study role of Provid compounds in cardiac function
|
9/20/2004
|
Provid Pharmaceuticals receives NIH
grant to fund multiple sclerosis research
|
6/1/2004
|
Provid Pharmaceuticals selected for
hit-to-lead and lead optimization medicinal chemistry support for
National Cancer Institute.
|
